An opportunistic take-over offer at 30 cents would be nice and juicy. That would be a 130% premium to the current share price.
P.S. Look at the 200 day weighted moving average of about 15.5 cents. Totally pathetic. Well done Starpharma.
P.S.S. If no take-over offer, I’m still expecting sub 10 cents later this year.
- Forums
- ASX - By Stock
- SPL
- SPL January 2024 technical analysis
SPL January 2024 technical analysis, page-2
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.2¢ |
Change
-0.003(3.16%) |
Mkt cap ! $37.90M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.2¢ | $281 | 2.974K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 890 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18223 | 0.090 |
1 | 50000 | 0.089 |
2 | 39232 | 0.088 |
3 | 167700 | 0.087 |
4 | 131361 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 890 | 3 |
0.095 | 28014 | 5 |
0.096 | 5125 | 2 |
0.099 | 6837 | 1 |
0.100 | 71848 | 3 |
Last trade - 10.50am 01/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online